Prevnar

Type: Product

Name: Prevnar

First reported Jun 10 2013 - Updated Jun 10 2013 - 1 reports

Celgene’s Abraxane: A Therapy for Advanced Pancreatic Cancer?

Kanak is a member of The Motley Fool Blog Network -- entries represent the personal opinion of the blogger and are not formally edited. This drug has already shown upward sales trend in treating metastatic breast cancer, and is expected to grow further ... [Published Motley Fool - Jun 10 2013]

Entities: Pancreatic Cancer, Celgene Corporation, Abraxane

First reported Jun 08 2013 - Updated Jun 08 2013 - 1 reports

GP gets straight to point in the vaccination debate

LOOK AT THE SCIENCE: Dr Scott Parsons says vaccination is“one of the most astonishing public health achievements of the last 100 years”.THE Sunshine Coast recently had the dubious honour of having one of the lowest levels of vaccination in Australia.This ... [Published Daily News - Jun 08 2013]

Entities: Vaccine, Pertussis, Public Health, MMR Vaccine

First reported Jun 03 2013 - Updated Jun 03 2013 - 1 reports

Celgene myeloma drug heads latest CHMP opinions

The latest set of opinions from advisors to the European Medicines Agency sees seven new medicines recommended for approval.Most notably, the agency's Committee for Human Medicinal Products (CHMP) has issued a positive recommendation on Celgene Corp's ... [Published Pharma Times - Jun 03 2013]

Entities: Celgene Corporation, myeloma, Drugs, Somatropin

First reported Jun 03 2013 - Updated Jun 03 2013 - 2 reports

Johnson & Johnson

Investors Turn Cautious on Dow Healthcare Stocks into Week’s End

Pfizer ( NYSE:PFE ): Current price $27.25The drug giant intends to issue benchmark bonds in its first dollar-denominated debt sale in over four years. As soon as Tuesday, Pfizer will offer three-, five-, 10- and 30-year securities, according to a knowledgeable ... [Published Wall St. Cheat Sheet - Jun 03 2013]

Entities: Johnson & Johnson, Pfizer Inc, UnitedHealth Group Inc, Stephen Hemsley

First reported May 31 2013 - Updated May 31 2013 - 1 reports

Boeing Company

Boeing Establishes New Engineering Centers and 2 Other Dow Movers to Watch

The Boeing Company ( NYSE:BA ): Current price $99.67On Friday, Boeing announced that it is setting up new centers for engineering design, propulsion and out-of-production airplane support for Commercial Airplanes, while it continues to lay the foundation ... [Published Wall St. Cheat Sheet - May 31 2013]

Entities: Boeing Company, Verizon Wireless, Long Term Evolution

First reported May 31 2013 - Updated May 31 2013 - 1 reports

Pfizer Inc

Pfizer Prevenar 13 gets EMA recommendation for extension of indication

The Committee for Medicinal Products for Human Use, CHMP, adopted a positive opinion recommending a variation to the terms of the marketing authorization for the medicinal product Prevenar 13, held by Pfizer. The CHMP adopted a change to an indication ... [Published Yahoo! Finance - May 31 2013]

Entities: Prevnar, Pfizer Inc, Streptococcus pneumoniae

First reported May 30 2013 - Updated May 30 2013 - 1 reports

Japan PAFSC Committee Approves Five New Drugs Including 13-Valent Pneumococcal Vaccine

Japan’s Pharmaceutical and Food Safety Council’s Second Committee on Drugs approved five new drugs, including the13-valent pneumococcal conjugate vaccine Prevenar 13 from Pfizer. ... [Published The Rose Sheet - May 30 2013]

Entities: Drugs, Japan, Prevnar

First reported May 28 2013 - Updated May 28 2013 - 1 reports

Three Things About to Move Pfizer Inc. (PFE) Stock

Large, multinational companies have an unprecedented number of things pulling and pushing on their share price. Pfizer Inc. (NYSE: PFE ) , the world’s largest pharmaceutical company, is no different. It can be difficult to keep up with every booming product, ... [Published InsiderMonkey.com - May 28 2013]

Entities: Pfizer Inc, Prevnar, Xeljanz, New York Stock Exchange

First reported May 26 2013 - Updated May 26 2013 - 2 reports

3 Things About to Move Pfizer Stock

Watch stocks you care aboutThe single, easiest way to keep track of all the stocks that matter...Your own personalized stock watchlist!It's a 100% FREE Motley Fool service...Large, multinational companies have an unprecedented number of things pulling ... [Published Motley Fool Discussion Boards - May 26 2013]

Entities: Pfizer Inc, Prevnar, Xeljanz, Zoetis Inc

First reported May 24 2013 - Updated May 24 2013 - 2 reports

Pfizer Has Potential To Grow Despite Decreasing Sales

Home » Blogs » Pfizer (PFE) is the world's largest research-based pharmaceutical company. It discovers, manufactures and leads the global market in prescription drugs and healthcare products. The company is struggling with deteriorating sales due to the ... [Published BioPortfolio - May 24 2013]

Entities: Pfizer Inc, Patent, Health Care, Biotechnology, Emerging Markets

First reported May 23 2013 - Updated May 23 2013 - 5 reports

Pfizer takes its shot at a vaccine for evasive superbug

ReutersChicago: Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar ... [Published msn.co.in - May 23 2013]

Entities: Vaccine, Pfizer Inc, Methicillin-Resistant Staphylococcus Aureus

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Pfizer points to pandemic potential of Prevnar 13

In pandemic flu preparation, a lot of focus is placed on protecting against the specific viral strain. Yet analysis of the 1918 pandemic shows secondary bacterial pneumonia directly caused many of the deaths. This brings Pfizer's ($PFE) Prevnar 13 into ... [Published FierceVaccines - May 22 2013]

Entities: Prevnar, Pandemic, Pfizer Inc

Quotes

"The decision does not mean that the vaccine itself is problematic from the viewpoint of safety. By implementing investigations, we want to offer information that can make the people feel more at ease" task force head Mariko Momoi said...

Japan withdraws recommendation of Merck and GSK HPV jabs [Published FierceVaccines - 12 hours ago]

Market Report, "Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningococcal Vaccine Segments to Drive Growth" , Published

Market Report, "Travel Vaccines Market to 2019 - Hepatitis A, Japanese Encephalitis and Meningoco ... [Published SBWire - Jun 18 2013]

Research and Markets (http://www.researchandmarkets.com/research/32gm2w/adult_and) has announced the addition of the "Adult and Adolescent Vaccines Market to 2018 - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in... "

Adult and Adolescent Vaccines Market to 2018 Report - Promising Novel Candidates in Late-Stage De ... [Published PR Newswire: General Business - Jun 06 2013]

More From BioPortfolio on "Japan PAFSC Committee Approves Five New Drugs Including 13-Valent Pneumococcal Vaccine"

Japan PAFSC Committee Approves Five New Drugs Including 13-Valent Pneumococcal Vaccine [Published BioPortfolio - May 30 2013]

More Content

sort by: Date \| Relevance
Japan withdraws recommendation of Merck and GSK... [Published FierceVaccines - 12 hours ago]
Market Report, "Travel Vaccines Market to 2019 ... [Published SBWire - Jun 18 2013]
SMO Fitzgerald Global - Pfizer Earnings Miss. [Published Pressbox.co.uk - Jun 18 2013]
Child vaccine shortage hurting most vulnerable [Published Asbury Park Press - Jun 15 2013]
Cervix vaccine issues trigger health notice [Published Japan Times - Jun 15 2013]
Celgene’s Abraxane: A Therapy for Advanced Panc... [Published Motley Fool - Jun 10 2013]
GP gets straight to point in the vaccination de... [Published Daily News - Jun 08 2013]
Adult and Adolescent Vaccines Market to 2018 Re... [Published PR Newswire: General Business - Jun 06 2013]
Celgene myeloma drug heads latest CHMP opinions [Published Pharma Times - Jun 03 2013]
Investors Turn Cautious on Dow Healthcare Stock... [Published Wall St. Cheat Sheet - Jun 03 2013]
Investors Turn Cautious on Dow Healthcare Stock... [Published Wall St. Cheat Sheet - Jun 03 2013]
Boeing Establishes New Engineering Centers and ... [Published Wall St. Cheat Sheet - May 31 2013]
US EQUITIES OPENING HEADLINES INCLUDING: Blackb... [Published Proactiveinvestors United Kingdom RSS feed - May 31 2013]
Pfizer Prevenar 13 gets EMA recommendation for ... [Published Yahoo! Finance - May 31 2013]
Pending EC decision: Prevenar 13, pneumococcal ... [Published Pending EC decisions and European Public Assess ... - May 31 2013]
Japan PAFSC Committee Approves Five New Drugs I... [Published The Rose Sheet - May 30 2013]
Japan PAFSC Committee Approves Five New Drugs I... [Published BioPortfolio - May 30 2013]
Three Things About to Move Pfizer Inc. (PFE) Stock [Published InsiderMonkey.com - May 28 2013]
3 Things About to Move Pfizer Stock [Published Motley Fool Discussion Boards - May 26 2013]
3 Things About to Move Pfizer Stock [Published EquityJungle - v0.1 - May 26 2013]
Pfizer Has Potential To Grow Despite Decreasing... [Published BioPortfolio - May 24 2013]
Pfizer Has Potential To Grow Despite Decreasing... [Published Seeking Alpha - May 24 2013]
Golden years health guidelines [Published The Villager - May 24 2013]
Scientist who invented HPV vaccine tackles MRSA [Published MSN News - May 23 2013]
Pfizer takes its shot at a vaccine for evasive ... [Published msn.co.in - May 23 2013]
Pfizer takes its shot at a vaccine for evasive ... [Published WDBJ7.com - May 23 2013]
Pfizer takes its shot at a vaccine for evasive ... [Published International Business Times Canada - May 23 2013]
Pfizer takes its shot at a vaccine for evasive ... [Published Reuters: Business News - May 23 2013]
FEATURE-Pfizer takes its shot at a vaccine for ... [Published Reuters - May 23 2013]
Pfizer points to pandemic potential of Prevnar 13 [Published FierceVaccines - May 22 2013]